drugset / Trial / NCT01848002
Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
This trial was conducted in Europe. The aim of this trial was to investigate safety and pharmacokinetics of multiple doses of catridecacog (recombinant factor XIII, rFXIII) in healthy volunteers.
Timeline
- Start
- 2003-05
- Primary completion
- 2003-08
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | catridecacog | Protein / enzyme biologic | 10 iu/kg | Intravenous |
| Subject | catridecacog | Protein / enzyme biologic | 25 iu/kg | Intravenous |